98 related articles for article (PubMed ID: 7546934)
1. [Dose-response relationship in the treatment of cervical dystonia with botulinum toxin type A (AGN 191622)--a phase II study].
Mezaki T; Kaji R; Kimura J; Mannen T
No To Shinkei; 1995 Sep; 47(9):857-62. PubMed ID: 7546934
[TBL] [Abstract][Full Text] [Related]
2. [The clinical usefulness of botulinum toxin type A for spasmodic torticollis and facial spasm].
Mezaki T; Kaji R; Kimura J; Osame M; Mizuno Y; Hirayama K; Maruyama S; Iwata M; Kanazawa I; Kinoshita M
No To Shinkei; 1995 Aug; 47(8):749-54. PubMed ID: 7546919
[TBL] [Abstract][Full Text] [Related]
3. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of Botox and a Chinese type a botulinum toxin in cervical dystonia].
Wan X; Tang X
Zhonghua Yi Xue Za Zhi; 1998 Feb; 78(2):131-4. PubMed ID: 10923426
[TBL] [Abstract][Full Text] [Related]
5. Botulinum A toxin treatment in spasmodic torticollis: report of 56 patients.
Poungvarin N; Viriyavejakul A
J Med Assoc Thai; 1994 Sep; 77(9):464-70. PubMed ID: 7706965
[TBL] [Abstract][Full Text] [Related]
6. Effect of botulinum toxin injection for achalasia in Thai patients.
Leelakusolvong S; Sinpeng T; Pongprasobchai S; Tanwandee T; Kachintorn U; Manatsathit S
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S67-72. PubMed ID: 17718248
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of a new bulk toxin of botulinum toxin in cervical dystonia: a blinded evaluation.
Racette BA; McGee-Minnich L; Perlmutter JS
Clin Neuropharmacol; 1999; 22(6):337-9. PubMed ID: 10626093
[TBL] [Abstract][Full Text] [Related]
8. Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin.
Neubrand M; Scheurlen C; Schepke M; Sauerbruch T
Endoscopy; 2002 Jul; 34(7):519-23. PubMed ID: 12170400
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin for people with dystonia treated by an outreach nurse practitioner: a comparative study between a home and a clinic treatment service.
Whitaker J; Butler A; Semlyen JK; Barnes MP
Arch Phys Med Rehabil; 2001 Apr; 82(4):480-4. PubMed ID: 11295008
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of hemifacial spasm with type A botulinum toxin (AGN 191622): a dose finding study and the evaluation of clinical effect with electromyography].
Mezaki T; Kaji R; Kimura J; Ogawa N
No To Shinkei; 1999 May; 51(5):427-32. PubMed ID: 10396749
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.
Truong D; Duane DD; Jankovic J; Singer C; Seeberger LC; Comella CL; Lew MF; Rodnitzky RL; Danisi FO; Sutton JP; Charles PD; Hauser RA; Sheean GL
Mov Disord; 2005 Jul; 20(7):783-91. PubMed ID: 15736159
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin treatment of lateral axial dystonia in Parkinsonism.
Bonanni L; Thomas A; Varanese S; Scorrano V; Onofrj M
Mov Disord; 2007 Oct; 22(14):2097-103. PubMed ID: 17685467
[TBL] [Abstract][Full Text] [Related]
13. [Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group].
Wissel J; Müller J; Heinen F; Mall V; Sojer M; Ebersbach G; Poewe W
Wien Klin Wochenschr; 1999 Oct; 111(20):837-42. PubMed ID: 10586488
[TBL] [Abstract][Full Text] [Related]
14. [Botulinum toxin in blepharospasm, in hemifacial spasm, and in cervical dystonia: results in 33 patients].
Novis SA; De Mattos JP; De Rosso AL
Arq Neuropsiquiatr; 1995 Sep; 53(3-A):403-10. PubMed ID: 8540813
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of spasmodic torticollis with local injections of botulinum toxin A].
Erbguth F; Kilian KD; Claus D; Neundörfer B
Dtsch Med Wochenschr; 1991 Apr; 116(15):567-72. PubMed ID: 2013263
[TBL] [Abstract][Full Text] [Related]
16. Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A.
Greene PE; Fahn S
Mov Disord; 1993 Oct; 8(4):479-83. PubMed ID: 8232357
[TBL] [Abstract][Full Text] [Related]
17. Treatment of sialorrhea in children with cerebral palsy: a double-blind placebo controlled trial.
Alrefai AH; Aburahma SK; Khader YS
Clin Neurol Neurosurg; 2009 Jan; 111(1):79-82. PubMed ID: 18977585
[TBL] [Abstract][Full Text] [Related]
18. Treatment of cervical dystonia with botulinum toxin.
Jankovic J
Mov Disord; 2004 Mar; 19 Suppl 8():S109-15. PubMed ID: 15027062
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
20. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
Bihari K
Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
